HAE
Price
$90.98
Change
+$3.33 (+3.80%)
Updated
Apr 26, 6:59 PM EST
11 days until earnings call
WAT
Price
$311.30
Change
+$3.22 (+1.05%)
Updated
Apr 26, 6:59 PM EST
9 days until earnings call
Ad is loading...

Analysis and predictions HAE vs WAT

Header iconHAE vs WAT Comparison
Open Charts HAE vs WATBanner chart's image
Haemonetics
Price$90.98
Change+$3.33 (+3.80%)
Volume$260.01K
CapitalizationN/A
Waters
Price$311.30
Change+$3.22 (+1.05%)
Volume$55.8K
CapitalizationN/A
View a ticker or compare two or three
HAE vs WAT Comparison Chart

Loading...

HAEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
WATDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
HAE vs. WAT commentary
Apr 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HAE is a Hold and WAT is a StrongBuy.

COMPARISON
Comparison
Apr 28, 2024
Stock price -- (HAE: $90.99 vs. WAT: $311.30)
Brand notoriety: HAE and WAT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HAE: 170% vs. WAT: 69%
Market capitalization -- HAE: $4.33B vs. WAT: $20.38B
HAE [@Medical Specialties] is valued at $4.33B. WAT’s [@Medical Specialties] market capitalization is $20.38B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HAE’s FA Score shows that 0 FA rating(s) are green whileWAT’s FA Score has 1 green FA rating(s).

  • HAE’s FA Score: 0 green, 5 red.
  • WAT’s FA Score: 1 green, 4 red.
According to our system of comparison, WAT is a better buy in the long-term than HAE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HAE’s TA Score shows that 6 TA indicator(s) are bullish while WAT’s TA Score has 4 bullish TA indicator(s).

  • HAE’s TA Score: 6 bullish, 4 bearish.
  • WAT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, HAE is a better buy in the short-term than WAT.

Price Growth

HAE (@Medical Specialties) experienced а +12.00% price change this week, while WAT (@Medical Specialties) price change was +5.13% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.43%. For the same industry, the average monthly price growth was -5.27%, and the average quarterly price growth was +16.21%.

Reported Earning Dates

HAE is expected to report earnings on Aug 06, 2024.

WAT is expected to report earnings on Jul 30, 2024.

Industries' Descriptions

@Medical Specialties (+0.43% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for HAE with price predictions.
OPEN
A.I.dvisor published
a Summary for WAT with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
WAT($20.4B) has a higher market cap than HAE($4.34B). HAE has higher P/E ratio than WAT: HAE (34.47) vs WAT (31.78). HAE YTD gains are higher at: 6.409 vs. WAT (-5.446). WAT has higher annual earnings (EBITDA): 1B vs. HAE (264M). WAT has more cash in the bank: 396M vs. HAE (194M). HAE has less debt than WAT: HAE (871M) vs WAT (2.44B). WAT has higher revenues than HAE: WAT (2.96B) vs HAE (1.27B).
HAEWATHAE / WAT
Capitalization4.34B20.4B21%
EBITDA264M1B26%
Gain YTD6.409-5.446-118%
P/E Ratio34.4731.78108%
Revenue1.27B2.96B43%
Total Cash194M396M49%
Total Debt871M2.44B36%
FUNDAMENTALS RATINGS
HAE vs WAT: Fundamental Ratings
HAE
WAT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
81
Overvalued
PROFIT vs RISK RATING
1..100
9562
SMR RATING
1..100
5915
PRICE GROWTH RATING
1..100
4654
P/E GROWTH RATING
1..100
7441
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HAE's Valuation (77) in the Medical Specialties industry is in the same range as WAT (81). This means that HAE’s stock grew similarly to WAT’s over the last 12 months.

WAT's Profit vs Risk Rating (62) in the Medical Specialties industry is somewhat better than the same rating for HAE (95). This means that WAT’s stock grew somewhat faster than HAE’s over the last 12 months.

WAT's SMR Rating (15) in the Medical Specialties industry is somewhat better than the same rating for HAE (59). This means that WAT’s stock grew somewhat faster than HAE’s over the last 12 months.

HAE's Price Growth Rating (46) in the Medical Specialties industry is in the same range as WAT (54). This means that HAE’s stock grew similarly to WAT’s over the last 12 months.

WAT's P/E Growth Rating (41) in the Medical Specialties industry is somewhat better than the same rating for HAE (74). This means that WAT’s stock grew somewhat faster than HAE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HAEWAT
RSI
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
66%
Momentum
ODDS (%)
Bullish Trend 3 days ago
67%
Bearish Trend 3 days ago
61%
MACD
ODDS (%)
Bullish Trend 3 days ago
58%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
67%
Bearish Trend 3 days ago
61%
Advances
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 6 days ago
64%
Declines
ODDS (%)
Bearish Trend 10 days ago
60%
Bearish Trend 4 days ago
57%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
65%
Bullish Trend 3 days ago
64%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
54%
View a ticker or compare two or three
Ad is loading...
HAEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
WATDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KRT27.310.25
+0.92%
Karat Packaging
FAMI0.84N/A
+0.07%
Farmmi
FTI26.59N/A
N/A
TechnipFMC plc
BLMN26.93-0.06
-0.22%
Bloomin' Brands
EBS1.92-0.03
-1.54%
Emergent Biosolutions

HAE and

Correlation & Price change

A.I.dvisor indicates that over the last year, HAE has been loosely correlated with LIVN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then LIVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
+3.80%
LIVN - HAE
43%
Loosely correlated
+0.78%
INSP - HAE
41%
Loosely correlated
+2.79%
STE - HAE
38%
Loosely correlated
+1.17%
VCYT - HAE
36%
Loosely correlated
-0.87%
WAT - HAE
36%
Loosely correlated
+0.96%
More